Approved uses of platform data

The following research proposals include both those approved by the platform’s independent Data Access Committee and those which are ISARIC Partner Analyses. Please review these proposals before submitting a Data Access Request. In the interest of maximising the production of evidence to reduce the impact of COVID-19, the platform aims to avoid unnecessary duplication of analyses.  

Creative rendition of SARS-COV-2 virus particles. Note: not to scale
i
Credit: National Institute of Allergy and Infectious Diseases, NIH

DAC approved proposals

These analyses have been approved by the COVID-19 Data Access Committee. 

 

The impact of SARS-CoV-2 variants of concern on disease severity of children

University of Queensland, Australia, NIHR Clinical Research Facility Southampton and University of Southampton, UK

Read the application

Predicting hospitalisation of COVID-19 patients using intelligent wearable technology with machine learning

Durban University of Technology, South Africa

Read the application

Global COVID-19 Clinical Data Platform for clinical characterization and management of hospitalized patients with suspected or confirmed COVID-19

World Health Organization, Switzerland

Read the full application

Formative Evaluation of a Minimally Viable COVID-19 Dataset

C-Path, United States

Read the full application

Pathogen evolution towards Evolutionarily Stable Strategies (ESS) in a socially age-structured epidemic

University of Oslo, Norway, University of Copenhagen, Denmark

Read the full application

Avoiding preventable deaths through the provision of essential treatment in critical illness in the COVID-19 pandemic

London School of Hygiene & Tropical Medicine and Centre for Global Development, UK, Ifakara Health Institute, Tanzania, and Karolinska Institute, Sweden

Read the full application

Sepsis in COVID-19

Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, China
Read the full application

COVID-Intelligence, a Bayesian Network Clinical Decision Support System for COVID-19

Monash University, Australia

Read full application

Clinical presentation and outcome of hospitalised Dutch patients with COVID-19

Franciscus Gasthuis and Vlietland, Rotterdam, The Netherlands

Read full application

 


ISARIC Partner Analyses

These analyses are submitted by researchers who contribute data to the ISARIC collaboration, and approved by the ISARIC governance committees.

ISARIC COVID-19 Clinical Data Reports

Data from the ISARIC collaboration are continuously analysed, reported and made available to the clinical, research, and public health communities.

Read the latest report

Read the preprint

 

Statistical and machine learning methods for predicting risk of pulmonary embolism and death in patients with COVID-19

University of Oxford and Queen Elizabeth Hospital, UK, Digital Health Research and Innovation Unit, Malaysia

Read the application

Comparing clinical presentation and outcomes of hospitalised SARS-CoV-2 patients before and after the spread of the Omicron variant

University of Oxford, UK, National Institute of Communicable Diseases, South Africa, King Abdulaziz Medical City, Saudi Arabia, Sunnybrook Health Sciences Centre, Canada, University College Dublin, Ireland, Franciscus Gasthuis & Vietland, Netherlands, University Hospital of Tubingen, Germany

Read the application

The relative influence of clinical and sociodemographic variables on the long-term COVID-19-associated QALYs lost

Harvard University, USA, University of Oxford and Imperial College London, UK, Universidad de La Sabana, Colombia, Oslo University Hospital, Norway

Read the application

Predicting Long-COVID Syndrome Machine Learning Models (PRELOCS)

National Institutes of Health, Malaysia

Read the application

Impact of COVID-19 in Pregnancy

Mount Kenya University and Ministry of Health, Kenya, University of Oxford and University of Birmingham, UK, Ifakara Health Institute, Tanzania

Read the application

Prevalence of use and outcomes of Non-invasive oxygenation strategies as first-line treatment of COVID-19 respiratory failure

Fondazione Policlinico Universitario, Italy

Read the application

Automatic Identification of Signals in Clinical Notes using Natural Language Processing

University of Oxford

Read the application

A tool-box for epidemic research: the ISARIC Clinical Characterisation group on strategies to simplify and improve collaboration-fuelled research during health emergencies

University of Oxford, UK, Apollo Hospitals, India, National Public Health Institute, Liberia

Read the application

Read the preprint

Read the paper

Cardiovascular comorbidities and complications in hospitalized patients with COVID-19

University of Oxford, UK, Serdang Hospital and Centre for Clinical Outcome Research, Malaysia

Read the application

Extracorporeal Membrane Oxygenation for COVID-19 Respiratory Distress Syndrome: a ISARIC Risk Factor Analysis

ALMA Mater Studiorum University of Bologna, Italy, Pablo Tobón Uribe Hospital, Colombia, and UMAE Hospital de Pediatria CMN, Mexico

Read the application

Characteristics, presentation, risk factors, treatments and outcomes in patients with cancer and COVID-19 (ARC: ISARC International Cancer)

University of Oxford and University of Liverpool, UK, and Universidad del Cauca and Pontificia Universidad Javeriana, Colombia

Read the application

Characterising SARS-CoV-2 Omicron vs Delta variant in terms of vaccination status, clinical presentation and outcomes

University of Oxford, UK

Read the application

Read the preprint

Characterization of long term Covid-19 outcomes in different populations: ISARIC Global Collaborative Adult Covid-19 Follow up analysis

University of Oxford, UK, Universidade de La Sabana, Colombia, and Sechenov University, Russia

Read the full application

Clinical outcomes in children with severe Covid-19: a retrospective study in limited vs. enormous resource countries

National Cardiovascular Center Harapan Kita, Universitas Udayana, and Saiful Anwar Hosptial, Indonesia, and Chonnam National University Children’s Hospital, South Korea

Read the full application

Lymphopenia in severe COVID19 patients: are they a unique immunologically compromised population?

Hospital São Francisco Xavier, Portugal, and University Technology MARA, Malaysia

Read the full application

Cardiovascular impact in COVID19 patients: a multicenter cohort analysis

Hospital São Francisco Xavier, and Universidade Algarve Portugal, and University Technology MARA, Malaysia

Read the full application

Liver function abnormalities in patients admitted with COVID-19 and association with outcomes: A draft analysis plan using data collected by the ISARIC Collaborators

Apollo Hospitals, India, University of Toronto, Canada, and University of Oxford, and ISARIC, UK

Read the full application

Applicability of commonly used COVID-19 clinical case definitions and severity score amongst patients hospitalized with COVID-19 in LMICs

Clinical Research Unit Nepal and Centre for Tropical Medicine and Global Health, University of Oxford, UK

Read the full application

COVID-19 among healthcare workers in a worldwide multicentre study: geographical distribution, characteristics and outcomes

National Institute for Communicable Diseases, South Africa and CUB-Hôpital Erasme, Belgium

Read the full application

Risk to admission of COVID19 patients from the Emergency Department

Universidad del Cauca, Colombia, and Hospital Universitario La Paz, Spain

Read the full application

Potassium in COVID-19 patients admitted to hospital

Inserm, Nancy Regional and University Hospital Center and INI-CRCT Network, France, and Hospital Civil de Guadalajara, Mexico

Read the full application

The utility and limitations of clinical trials and cohort studies to determine treatment efficacy during a disease outbreak

University of Melbourne, Australia, All India Institute Of Medical Sciences, India, and Sunnybrook Health Sciences Centre, Canada

Read the full application

Influence of nutrition status on COVID-related outcome

CUB-Hopital Erasme, Belgium

Read the full application

Read the paper

Utility of measures of oxygenation for COVID-19 case management and outcome

University of Oxford, UK, Apollo Hospitals Group, India, and Luxembourg Institute of Health, Luxembourg

Read the full application

Coagulopathy and thrombosis among COVID-19 patients

University of Utah School of Medicine, USA and Fundação Oswaldo Cruz, Brazil

Read the full application

Neurological manifestation and outcome for patients admitted to hospital with COVID-19

Johns Hopkins University School of Medicine, USA and University of Cape Town, South Africa

Read the full application

Read the paper

Acute Kidney Injury in COVID-19

University of Queensland, Australia and Universidad Mayor de San Simon, Cochabamba, Bolivia 

Read full application

Read the preprint

Read the paper

Analysis of the ISARIC International COVID-19 Critically Ill Cohort

British Columbia Children's Hospital, Canada and Universidad De La Sabana, Columbia 

Read full application

Read the paper

Development of a predictive analytics model for need of extracorporeal support in COVID-19

Washington University in St Louis, USA, INOVA Fairfax Hospital, USA and National Cardiovascular Center Harapan Kita, Indonesia

Read the application

Characteristics and outcomes of an international cohort of hospitalised patients with Covid-19 

University of Oxford, UK

Read the application

Read the preprint

International comparison of age-specific presenting symptoms for patients admitted to hospital with coronavirus disease 2019

University of Oxford, UK

Read full application

Read the preprint

Read the paper

Time variation in the inpatient journey

University of Oxford, UK

Read full application

Read the preprint

Read the paper